Welcome to our dedicated page for Innovate news (Ticker: VATE), a resource for investors and traders seeking the latest updates and insights on Innovate stock.
INNOVATE Corp. reports developments across a diversified portfolio organized around Infrastructure, Life Sciences and Spectrum. News commonly covers consolidated earnings, subsidiary performance, DBM Global cash dividends, steel construction activity, Spectrum network and broadcasting updates, and capital or operating developments within portfolio companies.
Life Sciences updates center on MediBeacon, an equity method investment developing fluorescent tracer agents and transdermal detection for kidney function assessment through the TGFR System, including FDA, NMPA and CE Mark regulatory milestones. INNOVATE also reports R2 system sales and commercial agreements as part of its portfolio-company operating updates.
INNOVATE Corp. (NYSE: VATE) has announced it will release its second quarter 2024 financial results on August 7, 2024, after market close. The company will host an earnings conference call on the same day at 4:30 p.m. ET to review the results, operations, and strategy.
Investors can access the live call through INNOVATE's Investor Relations website at www.innovate-ir.com. For those unable to listen live, a replay will be available shortly after the call on the same website. The conference call can be accessed via phone using the following details:
- Domestic Dial-In: 1-800-717-1738
- Toll/International: 1-646-307-1865
- Conference Number: 1133462
The conference replay will be available until August 20, 2024.
INNOVATE Corp. announced first quarter 2024 results, with $315.2 million in revenue, a 0.8% decrease from the previous year. Net loss was $17.7 million, a 73.5% increase, with $12.8 million Adjusted EBITDA, up 161.2%. DBM Global had $307.9 million in revenue, R2 had record North America sales, and Broadcasting saw revenue growth from new network launches.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.